For all to live out
their lives with dignity
FOR ALL TO LIVE OUT
THEIR LIVES WITH DIGNITY
We will continue to expand the possibilities of healthcare with the help of technology and by creating new systems.
By utilizing data and technology, people will be able to receive optimal and high-quality healthcare anywhere and at any time.
By putting the systems in place, people will be able to choose their own way of life, and after getting sick.
By increasing the number of healthcare options available, we hope that people will not have to meet their end while thinking “it wasn’t supposed to be like this.”
Everyone needs to live and pass on with dignity.
That is the world that we are committed to creating.
BUSINESS 01 Telehealth
We provide online services that connects patients with doctors, pharmacists, and other healthcare professionals online. By expanding the concept of communication, which has been limited to face-to-face interaction in the past, we will improve the quality of medical care.
Telemedicine service “curon”
curon is a telemedicine service that MICIN started providing, beginning from April 2016. It allows all services to be completed online; from making appointments to medical history taking, consultation, and delivery of medication or prescription.
Telepharmacy service “curon medication support”
curon medication support is an online service for pharmacies, which provides medication guidance by pharmacists to patients at home via phone or video call.
Pharmaceutical marketing and medical support services
We are developing services with pharmaceutical companies and medical device manufacturers to support the continuation of treatment in various disease areas.
BUSINESS 02 Decentralized Clinical Trials
The research and development of pharmaceutical products is undergoing a period of great change with the emergence of various modalities.
In this context, we will propose not only conventional clinical development methods, but also various clinical development methods, using digital tools that will enable the creation of new added value for patients.
Telemedicine which utilizes the vast information that has been cultivated through actual clinical experiences, will replace the conventional face-to-face medical treatment in clinical trials. It will also enable to reduce the burden of hospital visits and accelerate case registration.
By digitizing clinical trial data in a way that is closely aligned with the day-to-day operations of medical institutions and sponsors, we will not only improve data quality, but also promote the reduction of clinical trial operations and development costs.
BUSINESS 03 Digital Therapeutics
Through medical evidence-based software interventions, we are developing methods for supporting not only disease management but also prevention, diagnosis, treatment, and interventions. Our aim is to create a world where people face treatment with acceptance and are at ease living with treatment.
Developed MedBridge, a perioperative care application for patients undergoing surgical operations. MedBridge Heart Care, which is specialized for the perioperative period in cardiovascular surgery, was launched in July,2021 in limited areas.
BUSINESS 04 Insurance
We aim to create a world, where people can choose their own way of life, by updating insurance with healthcare and technology.
Healthcare continues to evolve, and the number of diseases that can be found and cured is increasing rapidly.
As a result, there are more options available than ever.
To this end, we will continue to allow people to get insurance when they really need it and receive the coverage they really need, especially for people who want to receive a higher quality of medical care and live according to their own way of life.
TEAM Top players in the field of medicine and technology have gathered here.
原 聖吾 Seigo Hara CEO and MD
Seigo has been committed to improving the healthcare system throughout his career; namely, through his work at International Medical Center of Japan, Health and Global Policy Institute, and McKinsey prior to founding MICIN. MD from the University of Tokyo, MBA from Stanford University.
COMPANY COMPANY PROFILE
- Company Name
- MICIN, Inc.
- 13F, Nippon Building, Otemachi 2-6-2, Chiyoda-Ku, Tokyo, 100-0004[MAP]
- 03-4577-9060 (Representative)
- Date of Establishment
- November 26, 2015
- 100 million yen (as of Dec. 2021)
- Representative CEO
- Seigo Hara(CEO and MD)
- Principal Business
- Telehealth Business
Decentralized Clinical Trials Business
Digital therapeutics Business
Insurance Business, etc.
- Origin of the Company Name
- MICIN is named as an homage to a medical artificial intelligence called Mycin, which was created at Stanford University in the 1970s.
Mycin, an algorithm for diagnosing contagious blood diseases and recommending antibiotics, reportedly boasted higher diagnostic results than the average physician, though not as high as specialists.
MICIN will contribute to the realization of a world that allows “For All to Live Out Their Lives With Dignity.”
We will use healthcare information effectively to advance technology and practice in the healthcare field. MICIN was created by combining Mycin and MI, which stands for Medical Information. Since our founding in 2015, we have been striving to realize our vision.